Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results (57)

« Back to Publications

Dose-response considerations in transdiagnostic antidepressant effects of lurasidone: response to Chen et al: commentary, Ghenciulescu & De Giorgi.

Ghenciulescu A. and De Giorgi R., (2026), Br J Psychiatry, 1 - 2

Disparities in diabetes treatment and monitoring for people with and without mental disorders: a systematic review and meta-analysis.

Wagner E. et al, (2026), Lancet Psychiatry, 13, 112 - 124

The distinctive psychopathology of NMDAR-antibody encephalitis compared with primary psychoses: an international, multicentre, retrospective phenotypic analysis.

Al-Diwani A. et al, (2026), Lancet Psychiatry, 13, 47 - 61

The renin angiotensin system in cognitive flexibility: Effects of single-dose losartan on task-switching in healthy volunteers

Prasad D. et al, (2025)

Epilepsy and mental health disorders: current challenges and potential solutions.

De Giorgi R. et al, (2025), Br J Psychiatry, 1 - 8

The distinctive psychopathology of NMDAR-antibody encephalitis by comparison to primary psychoses: a retrospective international multi-centre analysis

Irani S. et al, (2025), The Lancet Psychiatry

A Survey of Preferences for Sensing Technologies in People with Severe Mental Illness Admitted to an Acute Psychiatric Unit.

Barrera A. et al, (2025), Ann Biomed Eng, 53, 2372 - 2383

Transdiagnostic efficacy of lurasidone on depressive symptoms: systematic review and meta-analysis of randomised controlled trials.

Ghenciulescu A. et al, (2025), Br J Psychiatry, 1 - 10

Glucagon-like peptide-1 receptor agonists for major neurocognitive disorders.

De Giorgi R. et al, (2025), J Neurol Neurosurg Psychiatry, 96, 870 - 883

Supporting the call for clinical trials assessing physical exercise and creatine in depression: a response to "Muscle and the mind: The combination of creatine and exercise for depression?".

Sherpa NN. and De Giorgi R., (2025), Eur Neuropsychopharmacol, 96, 7 - 8

Glucagon-Like Peptide 1 Receptor Agonists and Mental Health: A Systematic Review and Meta-Analysis.

Pierret ACS. et al, (2025), JAMA Psychiatry, 82, 643 - 653

The value of mental science: we publish what matters.

Malhi GS. et al, (2025), Br J Psychiatry, 227, 429 - 433

Effects of 28-day simvastatin administration on emotional processing, reward learning, working memory, and salivary cortisol in healthy participants at-risk for depression: OxSTEP, an online experimental medicine trial.

De Giorgi R. et al, (2025), Psychol Med, 55

Acute angiotensin receptor blockade and mnemonic discrimination in healthy participants.

Prasad D. et al, (2025), J Affect Disord, 375, 293 - 296

Preliminary evidence should be treated as such: Response to "Is creatine useful as adjuvant in cognitive-behavioural therapy for depression?".

De Giorgi R. et al, (2025), Eur Neuropsychopharmacol, 93, 15 - 16

Load More